Anne DeGheest founded MedStars in 1986 and specializes in Medical Devices, Services and Healthcare Information Systems. She has held leadership positions in starting or building new Life Science companies with a cumulative market cap today over $6 Billion, including Aspect Medical (Nasdaq: ASPM), ProDuct (acquired in 2001 by Cytyc Corporation), Visicu (acquired in 2008 by Philips) and VISX (acquired in 2005 by AMO). Anne serves on the board of directors of Immersion Corporation (Nasdaq: IMMR) and is the founding investor and board member of Pixel Optics. She is on the device screening committee of the Life Science Angels. She was an early investor and key advisor to Thermage (Nasdaq: THRM) and Masimo (Nasdaq: MASI). She was the CEO of medpool.com that she founded while an entrepreneur in residence with Institutional Venture Partners. She was also involved in the successful startup of three well-known medical companies. Anne was the founding Vice President of Marketing at Omnicell Technologies (Nasdaq: OMCL), a market leader in automated point-of-use management systems for medical supplies. Anne was instrumental in the turnaround of Pyxis, which created and then dominated a new market segment in automated hospital drug dispensing. Cardinal Healthcare purchased Pyxis in 1996. As a marketing director for Nellcor, Anne started the pulse oximetry revolution. Nellcor went public and then was sold to Malinckrodt in 1996. She held sales and marketing management positions at Raychem where she was instrumental in starting a new division in the computer and telecommunication industry. She has a Master in Commercial Engineering from the University of Brussels, Belgium and a Master in Business Administration from Harvard.

Direct Line: (650) 917 9254

Bob Molinari specializes in biotechnology reagents, genomics, proteomics, and biopharmaceutical research companies. He is the founding CEO of Retrotope, focused on controlling metabolic processes associated with the oxidative stress conditions. He was the founding CEO of Coda Genomics/Verdezyne, a computation proteomics and biofuel company. Bob is on the biotech screening committee of the Life Science Angels. Bob serves on the board of Lypro Biosciences and Allylix Inc. He served as a genomics affiliate to the Institute for the Future, a Menlo Park-based think tank. He was the co-founding CEO and president of Protogene Laboratories, Inc., and from 1994 to 1996 led that company to become the world's largest supplier of custom DNA before it was acquired by Life Technologies, Inc. (now Invitrogen). He then ran a spin-off of Protogene for several years which developed ink jet technology for custom DNA chips. Prior to Protogene, Bob served as a strategic advisor in the startup of Nanogen, Affymetrix, and Sequenom. Earlier, Dr. Molinari served as the founding CEO of Avitech Diagnostics, a company with DNA sequencing and mutation detection technology (which became part of Variagenics, Inc.) and was a consultant specializing in biotechnology at McKinsey & Co. Dr. Molinari has an A.B. and an MBA from Dartmouth College and a Ph.D. in biophysical chemistry from Brown University.

Direct Line: (650) 917 9256